PharmaView   Aug.2006

Pharmaceutical Marketers are facing increasing pressures: increasing competition; squeezed margins; shrinking budgets; more to do and less time to do it. It’s becoming difficult to work any harder, and of course it's always better to work smarter. Therefore we bring you the PharmaView.

PharmaView is a biweekly educational and informative newsletter for improving readers’ marketing knowledge and reporting the latest news in the pharma industry. It also provides great opportunities to exchange ideas, network and be recognized among your peers in the industry.

Through PharmaView, you can:

Learn peer’s experience in pharma marketing

Stay in touch with what’s happening in pharmaceutical marketing today

Be on the pioneering edge of pharmaceutical marketing

Have networking / idea exchange opportunities

Integrating local knowledge with international perspective, Consultech Co. Ltd. offers its clients and prospects one-lstop solutions with sales and marketing consultancy, advertising and promotion strategies.

Shanghai Office Moves to Accommodate Expanding Business

We have much pleasure in announcing that, starting from Aug 18, 2006, Consultech Shanghai Office has moved to our new office building for better service of our Southeast clients. The business expansion of our shanghai office is also a powerful support and complement of Beijing-based business of Consultech.

The new office is located at Suite 1809, Haitong Securities Building, 689 Guangdong Road，Shanghai, China.200001（上海市黄浦区广东路689号海通证券大厦 1809室）.

Tel: +86 21 6341 1566

Fax: +86 21 63411567

Newly diagnosed epilepsy patients in Europe with partial onset seizures can now benefit from first-line treatment with Keppra® (levetiracetam). This advance in epilepsy management follows the approval of Keppra® by the European Commission as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.

Aug 18, 2006

Diabetics who take insulin injections may soon be free of the pain and discomfort of a needle prick, say scientists working to find easier, more effective ways for diabetics to take their insulin. Options being explored include new inhalers, insulin pumps, chewing gum, and even insulin pills that can be taken like a dietary supplement.

Aug 22, 2006

Parents will now be able to protect their infants against a potentially severe virus as Merck Frosst Canada Ltd. announced that Health Canada has approved RotaTeq(TM), the first and only vaccine available in Canada for use in preventing rotavirus gastroenteritis (serotypes G1, G2, G3, G4 and P1) in infants.

Aug 23,2006

High compression marketing supercharges drug revenues

Motivated by high research costs and short patent life, companies today utilize “high compression marketing” to drive a new drug brand share higher and faster. One result, a record $1 billion ine for Celebrex in only 10 months after launch. The qualities that a drug must possess, and the marketing tactics that need be applied, determine the potential success of a quick-time blockbuster.

Aug 15, 2006

Avoid the pitfalls to turn big mistakes into big wins in e-lmarketing

Successful utilization of the internet as part of a marketing communications strategy depends on knowing its pitfalls as well as its potential. The author outlines common mistakes and how to avoid them.

Aug 19, 2006

Pfizer Executive Shakeup

Pfizer announced that  Karen Katen, its vice chairman and head of U.S. pharmaceuticals, is resigning.

Aug 15,2006

Lilly's Arxxant Hits FDA Snag

Shares of Eli Lilly fell on Friday amid heavy trading volume after the drugmaker said U.S. health regulators delayed approval of an experimental treatment for diabetes-related complications.

Aug 18,2006

Vioxx, The Sequel

Merck is expected to soon reveal results from a study of its follow-up to Vioxx--potentially giving researchers clues to why that infamous drug caused heart attacks and strokes.

Aug 21,2006

Please feel free to offer your opinions and advices about PharmaView in order to better our services. Should you have any comments, or if you want to unsubscribe  from PharmaView, please send us an email: pharmaview@Consultech.com.cn  . Thank you!